NDT Advance Access first published online on March 14, 2007
This version published online on March 24, 2007
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm084
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| The first 10% of the full text of this article appears below. |
This
This article has been cited by other articles:
![]() |
F. Kleinclauss, M. Gigante, Y. Neuzillet, M. Mouzin, N. Terrier, L. Salomon, F. Iborra, J. Petit, L. Cormier, E. Lechevallier, et al. Prostate cancer in renal transplant recipients Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2374 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dantal and E. Pohanka Malignancies in renal transplantation: an unmet medical need Nephrol. Dial. Transplant., May 1, 2007; 22(suppl_1): i4 - i10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Campistol and F. P. Schena Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors Nephrol. Dial. Transplant., May 1, 2007; 22(suppl_1): i17 - i22. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Campistol, J. Albanell, W. Arns, I. Boletis, J. Dantal, J. W. de Fijter, S. A. Mortensen, H.-H. Neumayer, O. Oyen, J. Pascual, et al. Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance Nephrol. Dial. Transplant., May 1, 2007; 22(suppl_1): i36 - i41. [Abstract] [Full Text] [PDF] |
||||
